Key Summary:
- Higher TyG-WWI was modestly associated with incident cardiovascular disease.
- The index added little predictive value beyond conventional risk factors.
- Missing data and proxy criteria for CKM stage 3 limit generalisability.

A HIGHER triglyceride-glucose weight-adjusted waist index was linked to a modest increase in cardiovascular disease risk in a study of nearly 5,800 adults in China.
The index, known as TyG-WWI, combines fasting triglyceride and glucose measurements with waist circumference adjusted for body weight. It added little to risk prediction when researchers tested it alongside conventional risk factors.
The researchers analysed 5,788 adults from the China Health and Retirement Longitudinal Study. Participants had a median age of 59 years at the start of the study in 2011.
Through 2020, 1,407 participants reported a new diagnosis of cardiovascular disease made by a physician. This amounted to 32.3 events per 1,000 person-years.
The study included people across stages 0–3 of cardiovascular–kidney–metabolic (CKM) syndrome. The staging framework brings together metabolic, kidney and cardiovascular risk.
Researchers estimated CKM stages using measurements available in the survey. For stage 3, they used severely reduced kidney function or a Framingham risk score of at least 20%, because cardiac injury biomarkers and coronary artery calcium scores were unavailable.
The team found that the likelihood of developing cardiovascular disease rose as TyG-WWI increased. The association persisted after adjustment for demographic, lifestyle and biochemical factors (hazard ratio: 1.051, 95% confidence interval: 1.001–1.103).
The relationship was approximately linear, and the researchers found no statistically significant differences in the association across the subgroups they examined.
They then tested whether the index improved estimates of cardiovascular risk when added to a model containing established risk factors. None of the three measures of predictive improvement reached statistical significance.
The researchers included only participants with complete data. Differences between those included and those excluded may therefore have affected the results.
Participants reported their own cardiovascular diagnoses, and the survey-based criteria for stage 3 provided an approximation of that stage. These features limit how widely the findings can be applied to other groups of patients.
The authors suggested that TyG-WWI could serve as an additional measure for studying cardiovascular risk. Its value for predicting disease in individual patients remains uncertain, and further research would need to show whether it adds information in other populations with independently verified diagnoses.
Reference
Zhao P et al. The association of triglyceride–glucose-weight-adjusted waist index with cardiovascular disease risk in a population with operationalized cardiovascular–kidney–metabolic syndrome stages 0–3: Insights from CHARLS. J Diabetes Investig. 2026.
Featured image BJ Day Stock on AdobeStock
Each article is made available under the terms of the Creative Commons Attribution-Non Commercial 4.0 License.